Catalio Capital Management
Catalio Capital Management

Investor Overview

2020
Founded
1
# Portfolio
1
# Investments
2021
Latest Investment
0
# Exits
0
# Funds
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.

News

Team (3)

NameTitleContact
R. Jacob VogelsteinManaging Partner
George PetrocheilosManaging Partner
Tom V. BrooksGeneral Partner

Portfolio (1)

StartupStatusFoundedEmployeesFunding
ImmunaiImmunaiActive2019157$295.0M

Exits (0)

Funding Rounds (1)

RoundDateAmountInvestors
ImmunaiImmunai Series A2021$60.0M6

Funds (0)

Co-Investors (6)

InvestorInvestor TypeLocationPortfolio
Viola VenturesVenture CapitalIsrael69
TLV PartnersVenture CapitalIsrael48
Schusterman Family InvestmentsFamily OfficeIsrael8
Duquesne FamilyFamily OfficeUnited States2
Dexcel PharmaCompanyIsrael2
Catalio Capital ManagementVenture CapitalUnited States1

Investment Summary

Investment Pace

Stage Focus

Focus

Venture Capital

Investor Type

Pro Subscription Required

View all verified emails

With a Pro subscription, you can enjoy unlimited profile viewing, export our entire database, and view verified email contacts. Power your innovation efforts, uninterrupted.

$50/month

cancel anytime

Pro includes:

StartupHub.ai, the hub of the AI startup ecosystem.

Add or Claim Your Profile

Submit the form below to add or claim an existing profile. Within 24 hours, we'll review your request and connect you to your existing profile for full editing.

Pro Lite Subscription Required

Unlock all search results

With a Pro Lite subscription, you can enjoy unlimited profile viewing. Power your innovation efforts, uninterrupted.

$20/month

cancel anytime

Pro Lite includes: